Tianyin Pharmaceutical Co. released very positive full-year fiscal 2008 audited results, a year that ended June 30, 2008 for Tianyin. The company’s revenues grew 64% to $33.5 million while net income rose 51% to $6 million. The company reiterated that it expects a further increase in 2009 to at least $46 million in revenue and profit of $7.5 million. A few weeks ago, Tianying announced it expected 2008 numbers to hit these levels. More details...

Stock Symbol: (OTCBB: TYNP)